PFA
GNTX icon

Pathway Financial Advisers’s Gentex GNTX Stock Holding History

Pathway Financial Advisers’s Portfolio GNTX Stock Details GNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,210
Closed -$60.3K – 524
2022
Q4 		$60.3K Buy
+2,210
New +$59K 0.02% 230

Other funds holding GNTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Pathway Financial Advisers's GNTX Position: Q1 2023 in Review

Pathway Financial Advisers sold out of Gentex (GNTX) in Q1 2023, closing a stake of 2,210 shares — an estimated $60.3K sold.

Pathway Financial Advisers first reported a position in GNTX in Q4 2022 and held it in 1 quarter. The position peaked at $60.3K in Q4 2022. 481 funds tracked by Wall St. Rank hold GNTX as of Q1 2023.

  • Pathway Financial Advisers reported no remaining Gentex position as of Q1 2023 after selling out during the quarter.
  • Pathway Financial Advisers sold 2,210 Gentex shares in Q1 2023, an estimated $60.3K.
  • Pathway Financial Advisers first reported a position in Gentex in Q4 2022 and held it in 1 quarter.
  • Pathway Financial Advisers's Gentex position peaked at $60.3K in Q4 2022.
  • 481 funds tracked by Wall St. Rank held Gentex as of Q1 2023.

Based on Pathway Financial Advisers's 13F filing for Q1 2023, filed 19 Jul 2024.